Melinta Therapeutics Inc (NASDAQ:MLNT)

Delayed Data
As of 1:28pm ET
 +0.06 / +1.19%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Melinta Therapeutics Inc have a median target of 70.00, with a high estimate of 75.00 and a low estimate of 65.00. The median estimate represents a +1,275.25% increase from the last price of 5.09.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Melinta Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.60%
Growthannually 38.96%


Growthquarterly -52.66%
Growthannually -4.32%
Key to the earnings and sales forecast charts.